scorecardresearchGujarat Themis Biosyn Share Price Live NSE, BSE, Today - Gujarat Themis

Gujarat Themis Biosyn

BSE: 506879 | NSE: | ISIN: INE942C01045 | SECTOR: Biotechnology & Drugs

470.05 31.65 (7.22%)

13 Jun 2024, 10:29 (IST)
  • Open

  • High

  • Low

  • Prev Close

  • P/E

  • Median P/E

  • P/B

  • Median P/B

  • Market Cap

  • Volume

  • Vol. (20 day Avg.)

  • PEG

  • Div.Yield

  • Bid

  • Ask


Promoter Pledge Holding - 2.34%

Promoter NameNo of SharesPercentage
Pharmaceutical Business Group (India) Ltd17,00,0002.34%

Company Description

  • Biotechnology & Drugs
  • BSE

  • NSE

  • ISIN


Gujarat Themis Biosyn Limited is an India-based company, which is principally engaged in the manufacturing of pharmaceuticals and medicinal chemical products. The Company is focused on the business of manufacturing and sale of finished active pharmaceutical ingredients (API) products by fermentation process. The Company operates through manufacturing of the bulk drugs segment. Its product portfolio comprises Rifamycin-O and Rifamycin-S. The Company is manufacturing Rifamycin S, which is an intermediate for manufacturing the drug Rifampicin (an Antibiotic used for the treatment of several types of bacterial infections, including tuberculosis, Mycobacterium avium complex, leprosy, and Legionnaires' disease.) and Rifamycin O, which is an intermediate for manufacturing the drug Rifaximin (this is an Antibiotic used for treatment of traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy). Its research and development division focuses on developing fermentation cultures.

Company Officers

  • Tapas Thakurata

    Chief Executive Officer
  • Bharat Desai

    Chief Financial Officer
  • Kim Do-Deon

    Chief Technical Officer
  • Rahul Soni

    Compliance Officer, Company Secretary